In 2014 and 2016, Dale Bredesen MD, a neuroscience researcher, published case series demonstrating improvement and cognitive performance and brain volume loss in patients with Alzheimer’s Disease.  In 2017 he published a best-selling summary of his diagnostic and treatment approach – The End of Alzheimer’s – and offered a training for physicians in joint sponsorship with the Institute for Functional Medicine.  Dr. Rollow participated in this training, and has been offering care for patients with cognitive impairment based on it.

Although his case series are small in size (10 patients) without randomized controls, Dr. Bredesen’s results are important.  His method is quite consistent with what we do in functional medicine – essentially, seeking to identify and improve several dozen factors that he has found to be associated with the neurological changes that are present in Alzheimer’s.

Patients wanting to consider applying Dr. Bredesen’s method are invited to consult with Dr. Rollow.